Viewing Study NCT02870920


Ignite Creation Date: 2025-12-25 @ 4:06 AM
Ignite Modification Date: 2026-03-08 @ 4:12 AM
Study NCT ID: NCT02870920
Status: COMPLETED
Last Update Posted: 2023-12-08
First Post: 2016-08-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Durvalumab and Tremelimumab and Best Supportive Care vs Best Supportive Care in Patients With Advanced Colorectal Cancer
Sponsor: Canadian Cancer Trials Group
Organization:

Organization Data

Organization:
Class: NETWORK
Study ID: CO26
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View